Technology
Health
Pharmaceutical

Sienna Biopharmaceuticals

$0.7964
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.0264 (3.43%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell SNNA and other stocks, options, ETFs, and crypto commission-free!

About SNNA

Sienna Biopharmaceuticals, Inc. Common Stock, also called Sienna Biopharmaceuticals, is a clinical-stage biopharmaceutical company that focuses on the discovery, clinical development, and commercialization of aesthetics and medical dermatology. Read More Its products include Topical by Design platform for patients with inflammatory skin diseases and other dermatologic and aesthetic conditions through SNA-120, SNA-125, and SNA-001. The company was founded by Todd Harris and Frederick C. Beddingfield III on July 27, 2010 and is headquartered in Westlake Village, CA.

Employees
58
Headquarters
Westlake Village, California
Founded
2010
Market Cap
23.99M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
118.46K
High Today
$0.80
Low Today
$0.75
Open Price
$0.75
Volume
88.40K
52 Week High
$18.05
52 Week Low
$0.7196

Collections

Technology
Health
Pharmaceutical
Medical
Biopharmaceutical
2017 IPO
US
North America

SNNA Earnings

-$1.00
-$0.83
-$0.67
-$0.50
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 8, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.